Myasthenia Gravis Foundation of America, Inc.

Myasthenia Gravis Foundation of America, Inc.

Non-profit Organizations

Westborough, Massachusetts 2,874 followers

For a world without myasthenia gravis.

About us

Myasthenia Gravis Foundation of America (MGFA) is the largest, leading patient advocacy organization solely dedicated to finding a cure for the rare neuromuscular disease myasthenia gravis (MG) while improving the lives of people living with MG. More than 70,000 are diagnosed and living with MG in the United States alone. Those with myasthenia suffer profound, debilitating fatigue and muscle weakness that impact a person's ability to see, swallow, smile, walk or breathe. MGFA is focused on funding the most promising research discoveries for better treatments and a cure while providing impactful programs, guidance, and education to help support members of the MG Community.

Website
http://www.myasthenia.org
Industry
Non-profit Organizations
Company size
11-50 employees
Headquarters
Westborough, Massachusetts
Type
Nonprofit
Founded
1952
Specialties
Health, Rare Disease, Grant-Making, Foundation, and Patient Advocacy

Locations

  • Primary

    290 Turnpike Rd

    Suite 5-315

    Westborough, Massachusetts 01581, US

    Get directions

Employees at Myasthenia Gravis Foundation of America, Inc.

Updates

  • Find out why Carlos and his family will be at the MG Walk in New York on September 21. "Invisible illnesses" like myasthenia gravis are not invisible to those living with them. Take a moment to read this story. 💙

    View profile for Carlos Ortiz, graphic

    Global Account Manager | Turning Client Needs into Actionable Solutions | Focus on Driving Strategic Growth and Exceeding Client Expectations | Makes Things Happen

    Hello, It has been quite a while since I have been on here, but now is as good a time as any to dust off the cobwebs. I wanted to take a moment to share a deeply personal journey that has profoundly impacted my family over the past two years and changed our lives forever. My father, Juan Carlos Ortiz, has been courageously battling a rare autoimmune disease that affects less than 0.02% of the population: Generalized Myasthenia Gravis (gMG). This condition causes severe muscle weakness, affecting everyday activities such as speaking, swallowing, and breathing. MG is an "invisible" chronic disease where patients may appear fine but struggle with daily activities. Unfortunately, in rare cases, the condition has been proven fatal. Roughly 15-20% of individuals with MG will experience at least one myasthenic acute crisis at some point in their lives. My dad has had two myasthenic crises this year, resulting in two separate 6-night stays in the ICU. I recently attended my first HealthFair, which was hosted by the Myasthenia Gravis Foundation of America, Inc. this past May. It was the first time I didn't feel alone in the battle alongside my Dad. One of the speakers, Aimee Z., inspired me to begin my advocacy journey. Not many people are aware of Myasthenia Gravis, let alone what my family and I have been going through for the past two years. As my father's advocate, I have assumed power of attorney and healthcare proxy. I have navigated complex medical decisions to ensure he receives the best possible care. I now have a mission beyond personal caregiving; it has become my life's purpose to raise awareness about MG. I want to shine a light on its impact on my dad, our family, and the broader MG community. Raising awareness requires community support. Whether through sharing our story or joining/donating to our team, every action counts in making a difference for those affected by MG. On September 21st, our family will participate in a fundraising walk for the Myasthenia Gravis Foundation of America, Inc. (MGFA). This event aims to support critical research, education, and patient resources, essential for improving outcomes and finding a cure for MG. I understand that asking for your time to read the article I wrote below about my Dad is a big request, but I would appreciate your support in helping to raise awareness. You can make a difference by sharing this article or by joining and donating to our team. You can find my team page linked below. Juan Carlos Ortiz's Myasthenia Gravis Story: https://lnkd.in/gMqrAJN4 Team Page for Donations: https://lnkd.in/gRqEU3-q Together, we can bring much-needed attention to this rare disease and provide hope to individuals and families navigating similar challenges. If you or someone you know is struggling with MG, I am here to offer support in any way I can.

    • No alternative text description for this image
    • No alternative text description for this image
  • Featuring several MGFA Partners in MG Care, this discussion between expert neurologists focuses on variability in the presentation of myasthenia gravis (MG), guidance for diagnosis and personalization of care based on patient factors, and where targeted therapies can be utilized to control patient symptoms. Thanks to NeurologyLive for hosting this engaging discussion: https://ow.ly/civ950SBQ9r

    • No alternative text description for this image
  • Grateful for the support provided by partners like the PAN Foundation. If you need help paying for your medical bills related to your #myastheniagravis treatments, be sure to find out if you're eligible for their financial support program.

    View organization page for PAN Foundation, graphic

    7,818 followers

    It’s Myasthenia Gravis (MG) Awareness Month 💙 Did you know that more than 70,000 people have been diagnosed with MG in the United States? We’re proud to work with our alliance partner, Myasthenia Gravis Foundation of America, Inc., to not only provide financial assistance support to these patients but also educational and emotional support services. If you or someone you know is struggling with the out-of-pocket treatment costs from MG, our MG fund is currently open. Check your eligibility here 👉 https://ow.ly/8FpZ50SrHJT

    Myasthenia Gravis - PAN Foundation

    https://www.panfoundation.org

  • Because women under 40 are more likely than the general population to be diagnosed with myasthenia gravis, the question of having children comes up often in providers' offices. This recent article in ACNR - Neurology and Rehabilitation Journal highlights the current consensus-based practice in the United Kingdom regarding MG management in pregnancy. https://ow.ly/ZeEA50SfM1B

    Myasthenia Gravis and pregnancy | ACNR

    Myasthenia Gravis and pregnancy | ACNR

    https://acnr.co.uk

  • What is it like to watch a child go through life with a rare disease? And what if complex medical care is hard to find? Motunrayo A. shares the story of her daughter, Teniola, who was diagnosed with myasthenia gravis when she was three. Now living in Nigeria, the family faces obstacles to care, especially effective treatments. "As caregivers, most of our concern is for my child’s physical, emotional, and psychological wellbeing," Motunrayo says. "Other concerns are financial – we do spend a lot on treatment. There’s the lack of community, access to drugs, the emotional stressors." She shares that the online MG Community has made a world of difference for her. "Community is important. We only started feeling like we weren’t alone after I joined the MGFA's Instagram page. Reading about other people’s journeys gave us better perspective, and we felt less alone. You cannot do it alone. I’ve tried to explain the condition to people, but they just don’t get it. Having an MG community is everything. The people you’re talking to already get it. They will understand the frustration in your tone, they will freely share their journey. They will encourage. Reading up on new research and drugs has also kept our spirits up. Knowing that there is work going on behind the scenes and that there is hope in turn gives us hope for brighter days ahead." MGFA is working alongside other patient advocacy organizations to provide more resources to patients and caregivers beyond the United States, where it's needed most. To support these efforts, visit https://ow.ly/cixJ50Shv96. Learn more about the family's story on the MGFA blog - https://ow.ly/zv0Z50Shv94

    • No alternative text description for this image
  • MGFA is excited to announce a new MG Helpline that will provide you with emotional support, wellness strategies, and resource guidance. This is an important resource you have been asking for, and we are very excited to launch the helpline today! Your calls will be answered by counselors who can help you better navigate your #MyastheniaGravis journey and direct you to information and resources. While they can't provide medical advice or diagnosis, our helpline staff will be ready to listen and help. We hope this resource helps you feel empowered to learn more about managing MG and equip yourself with the resources you need to take care of yourself or your loved one. Reach out to the MG Helpline today at 1-833-647-8764 (1-833-MGSTRNG). Calls will be answered 8 a.m. to 8 p.m. Eastern.

    • No alternative text description for this image
  • We're excited to hear from these three #MGWarriors and talk about the power of taking action, raising awareness, and making a difference for the MG Community! Follow us on Instagram to participate. Thanks, Johnson & Johnson Innovative Medicine, for partnering with us on this event and for your continued investment in our vision of A World Without MG!

    View organization page for Johnson & Johnson Innovative Medicine, graphic

    998,859 followers

    Myasthenia gravis (MG) is an autoimmune disorder that causes symptoms including blurred or double vision, slurred speech, and chronic fatigue. It’s a rare disease best described by the patients who experience MG firsthand. That’s why, in honor of MG Awareness Month, we’ve partnered with the Myasthenia Gravis Foundation of America, Inc. on a compelling Instagram Live event, featuring the MGFA's Meridith O’Connor in a conversation with MG advocates, Tasha White (My Walk with MG) and Audrey Getman. Make sure you mark your calendars and tune in for an inspiring discussion around the challenges and triumphs of living with MG, personal diagnosis journeys, and words of wisdom for people navigating autoantibody diseases. To join the Instagram Live event, open Instagram, follow @myastheniaorg, and tune in on Tuesday, 6/18 at 6:30 PM ET. #JNJNeuroscience #JNJImmunology #MGAwarenessMonth

    • Instagram Live “MG MinGle: Turning Awareness into Action”; Tuesday, 6/18 6:30 PM ET and displays the “MGFA Host” as Meridith O’Connor from the Myasthenia Gravis Foundation of America (@myastheniaorg)” with Meredith’s headshot. The image also shows headshots from the two featured speakers, Tasha White, and her Instagram handle @m_w_w_mg and Audrey Getman and her Instagram handle @audreygetman_mgstrong. Image includes the Johnson & Johnson logo.
  • Last call: submit your abstract for the 2024 MGFA Scientific Session by Wednesday, June 14, 2024. The MGFA Scientific Session provides neurologists and other physicians an opportunity to share their basic or clinical research work on myasthenia or other disorders of the neuromuscular junction. This year’s session will be held on Tuesday morning, October 15, 2024, at the Savannah Convention Center in Savannah, Georgia. The session is part of the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting. Abstracts should address myasthenia gravis or other disorders of the neuromuscular junction, and anyone is welcome to submit. Abstracts will be evaluated based on the quality of the research or information presented. Full guidelines are available on AANEM's website, and feel free to reach out at mgfa@myasthenia.org with questions. https://ow.ly/jC4l50SfLNB

    • No alternative text description for this image
  • Join us June 20 for a webinar about Efgartigimod IV, an FcRN inhibitor. This exciting clinical trial involves people with all kinds of generlized MG (AChR, MuSK, LRP4, and seronegative). It's important to involve individuals with a variety of auto-antibodies in clinical trials so researchers can find out how effective treatments are for each clinical presentation. We are optimistic to see more inclusive studies, as it gets us closer to a world where ALL people with the disease have access to effective treatments. Our speaker is Dr. Jeffrey Guptill, neuromuscular franchise lead in clinical development at argenx, the sponsors of this trial. Register today: https://ow.ly/rAuX50Sfxmg #myastheniagravis #clinicaltrial argenx

    Research Webinar: argenx Clinical Trial Update – Adapt Seron

    Research Webinar: argenx Clinical Trial Update – Adapt Seron

    myasthenia.org

  • How are advances in testing and treatments for myasthenia gravis impacting diagnosis and symptom control for this chronic disease? Dr. Silvestri, a member of the MGFA's Medical & Scientific Advisory Council, provides an overview of MG along with emerging treatments in the April issue of Practical Neurology. #MyastheniaGravis #MGAwarenessMonth https://ow.ly/zZXK50S4Fmi

    Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments - Practical Neurology

    Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments - Practical Neurology

    practicalneurology.com

Similar pages

Browse jobs